Introduction
============

Cardiovascular disease (CVD) and osteoporosis (ie, reduced bone mass and microarchitectural deterioration of bone) are major health problems in North America, whose incidence increases with advancing age ([@b154]). The socioeconomic and health care burden of osteoporosis and CVD on society is enormous ([@b72]). Osteoporotic fractures ([@b23]) and CVD-related events are key origins of morbidity and premature mortality in the elderly ([@b154]). Moreover, post-menopausal women appear to be particularly at risk for developing both osteoporosis and CVD. In fact, once a woman reaches menopause, the risk for both osteoporosis and CVD increases substantially. Moreover, CVD and osteoporosis are often observed in the same individual ([@b123]).

Globally, CVD is a major cause of premature mortality accounting for approximately one-third of the cases of death. According to the World Health Organization approximately 17 million people die as a result of CVD each year ([@b166]).

In the United States, approximately 10 million individuals have osteoporosis and approximately 34 million are at an increased risk owing to low bone mass ([@b105]). Approximately 80% of those affected with osteoporosis are women ([@b105]). In Canada, approximately 1.4 million suffer from osteoporosis ([@b106]). In North America, 20%--25% of women over the age of 50 have osteoporosis ([@b106]) and approximately 50% are estimated to have low bone mass ([@b105]).

For years, osteoporosis and CVD were thought to be independent chronic diseases that increased markedly with advancing age. However, increasing evidence now supports a direct association between these chronic conditions. Accordingly, in this article we review the risk factors and patient profiles leading to both CVD and osteoporosis. Moreover, we review the mounting evidence that reveals an association between these diseases. We also discuss methods of reducing the risk for each chronic condition and the effects of these interventions on the subsequent risk for each disease. We discuss the differential rates with which osteoporosis and CVD affect men and women, and highlight how a holistic approach to these chronic conditions is warranted.

Traditional risk factors and patient profiles
=============================================

Cardiovascular disease
----------------------

Several traditional major independent risk factors for CVD have been identified including non-modifiable (family history, male sex, and advancing age) and modifiable risk factors. The major modifiable risk factors for CVD include elevated blood pressure, cigarette or tobacco smoking, physical inactivity, abnormal lipid lipoprotein profiles (eg, high total cholesterol, LDL cholesterol and triglycerides levels, and low levels of HDL cholesterol), unhealthy diets, excessive alcohol use, obesity, and diabetes.

Recent research has also identified several "merging" or "novel" risk factors that are independent predictors of CVD and premature mortality. This includes factors such as vascular health (eg, arterial compliance, carotid intima media thickness, and pulse wave velocity), left ventricular mass, and a series of novel blood parameters (eg, lipoprotein (a), fibrinogen, C-reactive protein, and homocysteine). The measurement of "emerging" risk factors in combination with a traditional lipid panel is thought to provide "information on risk over and above that supplied by established risk factors" ([@b67]).

The majority of CVD events are the result of atherosclerosis ([@b53]). The endothelium plays an important role in the process of atherosclerosis and thus has a significant effect on the long-term risk for CVD ([@b89]). Endothelial dysfunction is thought to be an obligatory first step in the process of atherosclerosis and has been observed in patients with coronary atherosclerosis ([@b130]) and individuals with risk factors for CVD ([@b31]). Therefore, a healthy endothelium is essential for the protection against atherosclerosis ([@b7]). Endothelial dysfunction has been associated with multiple CVD risk factors and has also been reported to occur prior to the development of atherosclerosis ([@b32]; [@b159]). It is important to note, that endothelial dysfunction has been observed in multiple chronic disease states including coronary artery disease, stroke, chronic heart failure, type 2 diabetes, hypertension, and obesity ([@b154]).

Cardiovascular disease places a significant burden upon health care systems worldwide. In Canada, CVD (including heart disease and stroke) is the leading cause of death (accounting for over one-third of all deaths) disability, and hospitalization accounting for approximately 17% of the total health care costs ([@b160]; [@b63]; [@b76]). Cardiovascular diseases cost the Canadian economy \$18 billion a year ([@b114]). Fortunately, CVD is largely preventable.

In developed countries, many adults have one or more risk factor for CVD. For instance, 80% of Canadians have one or more risk factor for CVD ([@b64]). As illustrated in [Figure 1](#fig1){ref-type="fig"}, the prevalence of modifiable risk factors for CVD in developed countries is alarming. Perhaps of more concern is the finding that many children and adolescents have risk factors for CVD. For instance, in a recent study we revealed that 58% of children (10--11 yr) had at least one elevated CVD risk factor and approximately 8% of the children had four or more elevated CVD risk factors ([@b99]). Clearly, effective prevention and treatment interventions are required across the lifespan.

![Prevalence of traditional risk factors for cardiovascular disease in Canadian society according to gender.\
**Note:** High cholesterol was defined as a plasma cholesterol level above of 5.2 mmol ·L^-1^; Diabetes was evaluated by self-report; Hypertension was defined as a blood pressure of ≥140/90 mmHg; Inactivity was defined as an usual daily leisure-time energy expenditure of \<1.5 kcal ·kg^-1^·day^-1^; Smoking was defined as daily tobacco smoking; Obesity was defined as a body mass index of \>27; Alcohol was defined as alcohol use in excess of 9 and 14 drinks per week for women and men, respectively.\
**Source:** Statistics Canada, National Population Health Survey, 1996/97 and the Heart and Stroke Foundation of Canada, The Changing Face of Heart Disease and Stroke in Canada 2000, October 1999 ([@b65], [@b133]).](vhrm0305-673-01){#fig1}

Osteoporosis
------------

Several non-modifiable and modifiable risk factors have been identified for osteoporosis. Non-modifiable risk factors include female sex (women are at greater risk), advancing age, personal history of a fracture after age 40, family history of osteoporosis, European or Asian ancestry, and dementia. Potentially modifiable factors include low BMI, calcium and vitamin D intake deficiency, physical inactivity, certain medications (eg, excessive use of corticosteroids), estrogen deficiency, current cigarette smoking, excessive alcohol consumption, early menopause (before age 45), and prolonged pre-menopausal amenorrhea (\<1 year) ([@b24]; [@b28]).

Osteoporosis is a major health burden affecting millions of people worldwide (particularly in developed countries) ([@b165]). In Canada approximately one in four women and one in eight men (over the age of 50) will have osteoporosis ([@b61]; [@b24]). In developed countries, it has been estimated that 40%--54% of 50 yr old women will have an osteoporosis-related fracture during their lifetime ([@b34]; [@b102]). The prevalence is higher amongst older adults; however, osteoporosis can present itself at any age ([@b28]). The incidence of osteoporosis is positioned to increase markedly over the next few decades owing to the increasing numbers of older individuals worldwide ([@b24]; [@b28]).

The burden osteoporosis places upon the individual, the family, and society as a whole is enormous. In Canada (1996 data) hip fractures were the second leading cause of hospital admission for women aged 65 years or older ([@b132]). It has been estimated that without the creation of effective prevention and treatment strategies Canada will spend \$1.9 billion per year to treat osteoporosis and related fractures ([@b106]).

Health-related quality of life is often markedly reduced in persons with osteoporosis. It has been estimated that 50% of women who sustain a hip fracture will become functionally dependent during activities of daily living, and 20% will require long term care ([@b34]; [@b24]). Moreover, the incidence of premature mortality is 20% higher within a year of suffering a hip fracture ([@b34]; [@b24]). Fortunately, osteoporotic fractures are preventable ([@b24]).

The interrelationships between risk factors for cardiovascular disease and osteoporosis
=======================================================================================

In recent years, a growing body of literature (see [Table 1](#tbl1){ref-type="table"}) has revealed an association between CVD and osteoporosis. In particular, epidemiological evidence has shown a relationship between vascular calcification and bone loss (as reviewed in [Table 1](#tbl1){ref-type="table"}). For instance, bone mineral density has been inversely associated with coronary and/or aortic calcification ([@b145]; [@b15]; [@b4]), and directly associated with high-density lipoprotein cholesterol (HDL-C) ([@b168]) ([Table 1](#tbl1){ref-type="table"}).

###### 

Relationship between vascular and bone health

  Investigation   Design                                                                          Population                                                                                                                          Primary outcome measures                                                                                                                                                                                                                                                                                                Key results
  --------------- ------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ([@b26])        Prospective, 2.8y                                                               9074 women, \>65y                                                                                                                   BMD (SPA); cause of death (ICD-9 codes)                                                                                                                                                                                                                                                                                 Each SD decrease in BMD of proximal radius resulted in a 70% increase stroke mortality.Age-adjusted BMD revealed a weak association with CV mortality.
  ([@b145])       Observational                                                                   30 women, 67--85y                                                                                                                   BMD (DXA); carotid plaque score (ulltrasound)                                                                                                                                                                                                                                                                           Linear correlation with BMD and plaque score.No association with L2-L4 BMD and plaque.
  ([@b147])       Observational                                                                   1292 women, mean age 71y                                                                                                            Blood flow-ankle/arm index; posterior tibial and brachial systolic BP; BMD (SPA and DXA)                                                                                                                                                                                                                                \>1SD change above mean annual index change resulted in reduced BMD at hip 2 fold vs. smallest SD change.A decrease of 2 SD in ankle/arm index was associated with a 3.7% decrease in hip BMD.
  ([@b148])       Observational                                                                   2051 women, \>65y                                                                                                                   Aortic calcification (lateral radiographs); BMD (DXA)                                                                                                                                                                                                                                                                   No significant association.
  ([@b15])        Observational                                                                   11 controls, 20 osteopenic, 14 women with osteoporosis, mean age 65y                                                                BMD (DXA), coronary calcium (QCT)                                                                                                                                                                                                                                                                                       Osteoporosis group had a significantly higher calcium score vs controls.
  ([@b149])       Longitudinal observational                                                      309 women, mean age 50y                                                                                                             Bone mass/BMC (SPA of forearm and lateral radiography of spine)                                                                                                                                                                                                                                                         50y group: Each SD decrease in bone mass resulted in a 43% increase in all cause mortality and 2-fold increase in CV death.
                  Recruited 1977--88, assessed 1994                                               754 women, mean age 70y                                                                                                             Cause of death (ICD-9 codes)                                                                                                                                                                                                                                                                                            70y group: Bone mass in lowest quartile was associated with a 2 fold increased risk of CV death vs highest quartile.
  ([@b55])        Longitudinal observational for \>9y                                             236 women, 45--64y                                                                                                                  Aortic calcification (radiographs), MCoA and RCoA                                                                                                                                                                                                                                                                       Progression of aortic calcification was associated with decreased MCoA (6.1%) and RCoA (8.9%).
                  Cross-sectional                                                                 720 women, mean age 63y                                                                                                                                                                                                                                                                                                                                                                                                                                     No progression was associated with decreased MCoA (3.9%) and RCoA (6.9%).Inverse, graded, association between extent of aortic calcification and MCoA/RCoA.
  ([@b74])        Longitudinal observational, 5.7y                                                6046 women, mean age 76y                                                                                                            Rate of BMD loss; cause-specific mortality                                                                                                                                                                                                                                                                              Each SD increase in rate of bone loss resulted in 1.3-fold increase in the risk of CHD death, 1.2-fold increase in the risk of atherosclerotic death and 1.6-fold increase in the risk of death due to pulmonary causes.
  ([@b81])        Longitudinal observational, 25--30y                                             346 women, 190 men, 28--62y at start of study                                                                                       Cortical bone mass (radiogrammetry); aortic calcification (radiographs)                                                                                                                                                                                                                                                 Each percent decrease of MCoA was associated with 7.3% increase in aortic calcification index in women.
  ([@b8])         Observational of a prospective cohort                                           524 Japanese American women, 43--80y                                                                                                BMD of distal/proximal radius and calcaneus (SPA); aortic calcification (lateral and AP radiographs)                                                                                                                                                                                                                    No significant association between osteoporosis and aortic calcification.
  ([@b168])       Observational                                                                   214 women, 47--86y                                                                                                                  BMD, TC, LDL-C, HDL-C, TG                                                                                                                                                                                                                                                                                               Inverse correlation with BMD and LDL-C.Positive correlation with BMD and HDL-C.Low TG levels associated with vertebral fracture.
  ([@b138])       Observational                                                                   963 women, 60--85 yr                                                                                                                Aortic calcification (graded on lateral lumbar radiographs), and BMD (at the distal radius, lumbar spine, proximal femur)                                                                                                                                                                                               Age, years since menopause, BMI, level of education, smoking history, and physical activity were significant common risk factors for AC and hip BMD.Aortic calcification was an independent predictor of hip BMD.In a subgroup analysis, women with a history of intermittent claudication showed more severe aortic calcification, lower hip BMD, and a higher prevalence of CHD compared to age-matched controls.
  ([@b80])        Prospective, longitudinal (10 yr) population-based survey                       N = 915, approximately 50% males and females (Mean Age approximately 59 yr)                                                         Serum OPG, incident CVD, carotid atherosclerosis                                                                                                                                                                                                                                                                        Prevalence and severity of carotid atherosclerosis increased progressively with higher levels of OPG (even after controlling for sex and age).OPG was a significant and independent risk factor for 10-year incident cardiovascular disease and vascular mortality.
  ([@b123])       Observational Cross-sectional and Longitudinal                                  *Cross-sectional*: 2348 postmenopausal women (50yrs and older) *Longitudinal*: 228 postmenopausal followed 9 months to 8 yr later   Aortic calcification, BMD, fracture                                                                                                                                                                                                                                                                                     *Cross-sectional*: Age-independent association between the degree of aortic calcification and bone density.Aortic calcification was associated with a 4.8 and 2.9-fold increase in the risk for vertebral and hip fractures, respectively.Bilateral hip fractures more common in those with calcification than those without.*Longitudinal:* Graded relationship between bone loss and the progression of vascular calcification.
  ([@b94])        Observational                                                                   5,050 women and men aged 50--79 yr                                                                                                  BMD, MI (self-report), BMI, glucose, cholesterol, HDL, medications (self-report)                                                                                                                                                                                                                                        Participants who reported prior MI had significantly higher odds of having low BMD (after adjusting for CVD and osteoporosis risk factors).MI was significantly associated with low BMD in men, but not women.
  ([@b139])       Multicenter, randomized, double-blinded, placebo controlled Followed for 4yrs   2576 women, mean age = 66.5 yr (assigned to placebo group)                                                                          Incidence of fatal or nonfatal CV events, BMD (femoral neck and lumbar spine), traditional risk factors for CVD (BMI, blood pressure, smoking habit, lipid profile, and history or presence of hypertension, diabetes, hyperlipidemia, cardiovascular disease, and/or related major interventions)                      Osteoporotic women had a 3.9-fold increased risk for cardiovascular events than women with low bone mass.Risk of cardiovascular events increased incrementally with the number and increasing severity of baseline vertebral fractures.Composite cardiovascular risk was higher in women with osteoporosis and they were also more frequent users of cardiovascular medications.The incidence of an acute cardiovascular event during the follow up was higher in women with osteoporosis (evident for both coronary and stroke events).Increased risk for cardiovascular events associated with osteoporosis could not be explained by common risk factors alone.
  ([@b4])         Longitudinal observational, 7.5 yr                                              N = 2662 Postmenopausal women, mean age = 65 yr                                                                                     Aortic calcification, BMD, vertebral fractures (X-ray), hip fractures (self-report)                                                                                                                                                                                                                                     Advanced aortic calcification at baseline was significantly related to lower BMD and accelerated bone loss at the proximal femur.The severity of aortic calcification was an independent predictor of hip fractures (OR = 2.3).
  ([@b68])        Observational                                                                   97 patients undergoing elective coronary artery bypass surgery                                                                      OPG, cardiac troponin I, electrocardiography, homocysteine, C-reactive protein                                                                                                                                                                                                                                          Positive correlation between OPG before surgery and the number of diseased vessels.Positive correlation between OPG before surgery and the number of bypasses.Strong correlation between OPG before surgery and homocysteineOPG level for four patients who experienced cardiac complications was elevated.
  ([@b127])       Observational                                                                   313 women (57 yr) and 167 men (55 yr)                                                                                               Coronary calcium burden, BMD, self-report CHD risk factors, medical history                                                                                                                                                                                                                                             The degree of coronary calcification was inversely associated with BMD in postmenopausal women. After controlling for age, this association was absent.
  ([@b73])        Prospective, longitudinal, 6 yr                                                 2,733 women, aged 55-74 yr                                                                                                          Carotid Artery (echogenic) plaques, nonvertebral fractures                                                                                                                                                                                                                                                              The age-adjusted relative risk of fracture was significantly higher in women with echogenic plagues (1.7 (95% confidence interval 1.0--2.7).
  ([@b12])        Observational                                                                   176 women, aged 60--85 yr                                                                                                           Genotyped for epsilon (varepsilon) allelic variants of the ApoE gene, and measures of serum lipids (total cholesterol, triglycerides, HDL-C, LDL-C, apoA1, ApoB, Lp(a)), hip and spine BMD, aorta calcification, radiographic vertebral fracture and self-reported wrist and hip fractures, and cardiovascular events   Presence of the ApoE varepsilon4 allele was associated with a worsened serum lipid profile, but had no association with spine/hip BMD or aortic calcification.After adjusting for age, the risk of hip fractures but not wrist or vertebral fractures was increased in subjects with advanced vascular disease.

**Abbreviations:** AP, anterior posterior; BMC, bone mineral content; BMD, bone mineral density; BP, blood pressure; CHD, coronary heart disease; CV, cardiovascular; DXA, dual energy x-ray absorptiometry; HDL-C, high-density lipoprotein-cholesterol; ICD-9, International Classification of Diseases (9th edition); L~2-4~, 2nd through 4th lumbar vertebrae; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; MCoA, metacarpal cortical area; PM, postmenopausal; QCT, quantitative computed tomography; RCoA, relative cortical area; SD, standard deviation; SPA, single photon absorptiometry; TC, total cholesterol; TG, triglycerides; OR, odds ratio; IMT, intimal medial thickening; OPG, osteoprotegerin; BMI, body mass index; MI, myocardial infarction.

Clinical populations have also revealed a relationship between CVD and osteoporosis. For instance, accelerated bone loss has been observed in diabetics ([@b124]), a group that commonly exhibits marked vascular dysfunction ([@b117]; [@b97]). Furthermore, in cases where vascular function is affected differentially on opposite sides of the body (ie, asymmetric vascular disease in the lower limbs), the side that has the greatest vascular dysfunction also displays the lowest bone mineral content ([@b87]; [@b86]). Moreover, in elderly individuals who have experienced a fracture at the femoral neck, the blood vessels supplying the proximal femur are often atherosclerotic ([@b21]; [@b22]). The rate of bone loss at the hip has also been shown to be greater in women who have the greatest reductions in blood flow (as assessed by the ankle/arm index) ([@b147]).

The potential relationship between these chronic conditions has important implications for the health of many individuals with (or at risk for) CVD and osteoporosis ([Table 1](#tbl1){ref-type="table"}) ([@b139]). For instance, investigations with post-menopausal women have observed that there is an increased risk of cardiovascular-related and stroke mortality for each standard deviation decrease in bone mass ([@b26]; [@b149]; [@b74]). For instance, [@b74] revealed that for each standard deviation decrease in bone mass there was a 1.2- to 1.3-fold increased risk of dying from coronary artery disease or other forms of atherosclerosis. [@b149] reported that the lowest quartile of bone mass was associated with a 2-fold increase in the risk for CVD-related death (vs. the highest quartile). [@b139] revealed that osteoporotic women had a 3.9-fold increased risk for cardiovascular events than women with low bone mass. This increased risk could not be explained by common risk factors alone. It is important to note however that studies have also shown no relationship between coronary calcification and osteoporosis after controlling for age ([@b127]).

It remains to be determined the key mechanism(s) responsible for the relationship between CVD and osteoporosis. As identified above, both chronic conditions share similar modifiable risk factors (such as physical inactivity, smoking, age, years since menopause, and excessive alcohol usage). However, researchers have shown a direct relationship between vascular disease and hip bone mineral density even after adjusting for a wide range of common risk factors (including age, years since menopause, BMI, level of education, current and previous smoking, and physical inactivity) ([@b138]). Therefore, CVD and osteoporosis also may be linked by common pathophysiological mechanisms ([@b138]). The available epidemiological evidence does not allow for the establishment of a causal link between CVD and osteoporosis. However, there are plausible biological pathways whereby diminished cardiovascular health can influence bone health and vice versa ([@b159]). Several excellent reviews have been created recently on these topics [@b37]; [@b60]; [@b115]).

Potential mechanisms
--------------------

There is evidence that vascular calcification has several common features to bone formation at both the cellular and molecular level. As stated by [@b37] "calcified atherosclerotic arteries can contain tissue that is histomorphologically indistinguishable from bone." Vascular calcium deposition is now thought to be an active, complex, and regulated process similar to new bone formation (or remodeling) that is not merely a consequence of aging ([@b37]; [@b120]). Importantly, calcifying vascular cells appear to have the ability to experience osteoblast differentiation ([@b120]). Moreover, it has been hypothesized that there are arterial cells that can differentiate into mineral resorbing cells (ie, osteoclast-like cells) ([@b38]). These cells are thought to be derived from hematopoietic precursors of the mononuclear phagocytic lineage ([@b38]). [@b38] postulated that osteoclast-like cells may play a role in the delicate balance of mineral deposition and resorption within the arterial wall (similar to that seen in bone). These authors also considered arterial mineral deposition "as a localized failure of protective mechanisms that actively oppose mineral deposition within the disordered metabolic milieu of developing atherosclerotic plaque." This supports a growing body of research that indicates that arterial calcification involves arterial osteoblast- and osteoclast-like cells ([@b37]).

Both the artery wall and the osteon of cortical bone have a common endothelium lined lumen. Cancellous bone is also highly vascular. Moreover, calcified plaque has been shown to have numerous cellular and molecular elements that participate in bone formation including (but not exclusive to) bone morphogenetic protein-2, collagen 1, osteonectin, osteopontin, matrix Gla proteins, osteocalcin and osteoprotegerin ([@b37]; [@b159]; [@b60]).

Several biological mechanisms (based primarily on animal models) have been proposed to explain the link between CVD and osteoporosis (see reviews of [@b37]; [@b60]; and [@b115]). Chronic inflammation is known to play a role in the development of both chronic conditions. For instance, proinflammatory cytokines (including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α)) have been associated with vascular disease ([@b20]) as well as increasing bone resorption ([@b35]). Also, both bone and the vasculature are affected by sex steroids ([@b135]; [@b118]). For example, estrogens play a role in CVD and osteoporosis via their effects on cytokines (including IL-6, osteoprotegerin (as discussed later), and TNF-α) ([@b14]).

As outlined above, vascular calcifications and bone have several similarities ([@b60]; [@b115]). Several compounds found within arterial wall calcifications have been implicated in the association between bone loss and CVD. For instance, osteoprotegerin (an important regulator of osteoclastgenesis) has recently received considerable attention. Osteoprotegerin is a member of the TNF receptor superfamily that serves as a bone resorption inhibitor by blocking the RANK-L/RANK interaction ([@b80]; [@b115]). Animal and human studies have reported conflicting findings regarding the role of osteoprotegerin in CVD and osteoporosis. Mice that do not have the osteoprotegerin gene exhibit vascular calcifications and osteoporosis ([@b27]). The intravenous administration of osteoprotegerin into mice deficient in osteoprotegerin reversed the osteoporosis, but it did not correct the arterial calcification. Whereas, the transgenic osteoprotegerin gene delivered during gestation prevented the formation of arterial calcification in osteoprotegerin deficient mice ([@b103]). In humans, a high level of osteoprotegerin has paradoxically been shown to be an independent risk factor for the progression of atherosclerosis and the development of CVD ([@b25]; [@b80]). Similarly, high levels of osteoprotegerin were observed in post-menopausal women with osteoporosis ([@b169]). Based on animal literature, it would be anticipated that high osteoprotegerin levels would be associated with high bone mineral density [@b60]). [@b169] postulated that the high osteoprotegerin levels (in osteoporotic post-menopausal women) may reflect a compensatory response to enhanced osteoclastic bone resorption.

Serum lipids (a well-established risk factor for atherogenesis) have been proposed as one common mechanism for CVD and osteoporosis. It has been postulated that oxidized lipid accumulation in the subendothelial space of arteries promotes arterial calcification and inhibits bone mineral formation ([@b109]). Lipids have been shown to have effects on osteoblasts ([@b111], [@b109], [@b108]) and osteoclasts ([@b141]). For instance, the same oxidized lipids that bring about osteoblast differentiation in calcifying vascular cells inhibit osteoblast differentiation in bone cells of mice ([@b111]). Moreover, in atherogenic susceptible and resistant mice exposed to a high fat or normal diet, a 35% decrease in both bone mineral content (BMC) and osteocalcin expression was found in the fat fed, atherogenic susceptible strain ([@b110]; [@b112]). Animal work also revealed that hyperlipidemia may lead to osteoporosis via an increase in osteoclastic bone resorption ([@b141]). Prolonged treatment with high-density lipoprotein has also been shown to inhibit the osteogenic activity of calcifying vascular cells. Moreover, HDL inhibited the osteogenic activity induced by inflammatory cytokines ([@b108]).

Epidemiological evidence in humans examining the role of lipids in the relationship between CVD and osteoporosis remains controversial. For instance, there is evidence that hyperlipidemia (eg, elevated low-density lipoprotein) is associated with reduced bone mineral density ([@b168]). However, abnormal lipid lipoprotein levels have also been shown to be associated with increased bone mineral density in humans ([@b1]). Whereas, others have found no independent relationship between lipids and bone mineral density ([@b12]). For example, [@b12] recently reported that there were no independent associations with lipid lipoprotein profile and bone mineral density of the hip or spine. Importantly, the authors also revealed that the severity of aorta calcification was independently associated with hip bone mineral density (with no contribution of lipids). The authors stated that these discrepancies provide evidence that the obstructive vascular disease (rather than lipid lipoproteins per se) facilitates the bone loss. The authors also postulated that lipids may act indirectly via the promotion of atherosclerosis which in turn can affect local bone metabolism. This effect is thought to be particularly evident at skeletal sites with end-arterial blood supply ([@b12]). This evidence supports the argument that a decrease in peripheral blood flow and supply could suppress bone cell function ([@b120]).

Endothelial function appears to be important for both vascular and bone health. The vascular endothelium provides a macromolecular barrier with multiple functions including: 1) anti-inflammation and pro-inflammation, 2) vasodilatation and vasoconstriction, 3) anti-thrombosis and pro-thrombosis, 4) anti-oxidation and pro-oxidation, and 5) growth inhibition and growth promotion ([@b159]). When the integrity of the endothelium is disrupted, as with oxidized LDL-C, an imbalance in these roles occurs resulting in endothelial dysfunction. Endothelial dysfunction is thought to be an obligatory first step in the process of atherosclerosis. Owing to the intimate contact with endothelial cells, the health of the endothelium appears to also be of great significance for bone health.

A healthy vascular tone is maintained by the continual release of low levels of nitric oxide (NO). NO is generated from L-arginine by NO synthase isoenzymes. Three NO synthase isoforms have been identified including a neuronal form (nNOS), an endothelial form (eNOS), and an inducible form (iNOS). Recently, it has become apparent that NO is involved in the process of bone metabolism and as such the influence of NO on bone health has been the focus of several investigations. In bone, it has been established that nNOS is rarely expressed, while both eNOS and iNOS are expressed ([@b43]). However, both the eNOS and nNOS isoforms affect bone differently. For instance, the eNOS isoform is expressed constitutively and is predominant in the osteoblast lineage ([@b43]). Inflammation is associated with iNOS activity in osteoblast and osteoclast cells ([@b43]; [@b11]; [@b12]). For instance, [@b12] revealed that the activation of the iNOS pathway contributes to inflammation-mediated osteoporosis via suppressed bone formation and osteoblast apoptosis. Osteoclasts have also shown low levels of eNOS and iNOS ([@b43]). eNOS negative (knock-out) mice have demonstrated reduced bone volume, bone formation rates, BMD, and osteoblast numbers ([@b3]; [@b9]; [@b121]). eNOS knock-out mice have also revealed a blunted response to exogenous estrogen, supporting the important role of eNOS in mediating the stimulatory action of estrogen on bone formation ([@b9]). Moreover, cells of osteoblast phenotype challenged with pulsatile fluid flow (as seen with exercise) have demonstrated increased eNOS production ([@b82]). Researchers have also shown that L-arginine administration prevented bone loss and bone collagen breakdown in cyclosporin A-treated rats ([@b42]).

These findings (from animal and cell culture models) indicate that NO may contribute to the osteogenic pathway. However, exactly how eNOS and iNOS contribute to bone health remains to be determined, especially in humans. Prospective human investigations have evaluated NO and bone ([@b70]; [@b104]). For instance, [@b70] revealed that intermittent nitrate use increased hip and heel BMD compared to non-users. However, there was no difference in fracture free survival between groups. A recent randomized controlled trial ([@b104]) revealed that isosorbide mononitrate (a NO donor) was effective in reducing a marker of bone resorption (urine N-telopeptide) and increasing a marker of bone formation (alkaline phosphatase) in post-menopausal women. The authors postulated that a NO donor may be effective in the prevention of post-menopausal osteoporosis. Additional research is required to clearly identify the roles that the specific NO isoforms have on bone health.

Other factors involved in arterial wall calcification have also been implicated in the relationship between CVD and osteoporosis. Potential factors include (but are not exclusive to) osteopontin, matrix Gla-proteins and osteocalcin, and leptin. It is recommended that interested readers consult reviews on this topic ([@b37]; [@b60]; [@b115]) for further information regarding the varied potential mechanisms explaining the relationship between CVD and osteoporosis.

Based on the above literature it is apparent that multiple pathophysiological mechanisms can be responsible for the observed relationship between CVD and osteoporosis. It is however important to note that many of the above findings provide evidence that vascular dysfunction plays a key role in the association between CVD and osteoporosis. Thus, impaired blood flow and a diseased vascular system may have negative effects on bone health, or diseased bone may impair vascular health ([@b159]).

Differences between men, pre-and postmenopausal women
=====================================================

It is important to discuss the differences between men and women across the lifespan with respect to the risk for and prevalence of CVD and osteoporosis. Often CVD is thought to be a disease of primary concern for men and osteoporosis of primary concern for women owing to the differential prevalence rates for each condition amongst sexes. However, these statements must be tempered greatly owing to the unique sex-based differences in each condition.

With respect to CVD, men are more prone to atherosclerosis (approximately 3--4 fold greater) than women ([@b39], [@b6]). With aging, this ratio declines to approximately 2 between the ages of 65--69, and to 1 by the age of 85 ([@b39]). The incidence of CVD increases markedly in women after menopause ([@b161]). It has been estimated that the coronary heart disease rates increase 2--3 fold after menopause in women (increasing with aging) ([@b6]). Recent American data indicates that the prevalence of coronary heart disease in women 75 years or older was 10.3% in comparison to 1.6% between the ages of 45--54 ([@b6]).

The majority of sudden cardiac deaths occur in men (approximately 3--4 fold greater incidence); however, this inequality is also reduced with advancing age ([@b6]). Men have been shown to have a higher blood pressure than women until approximately age 45; thereafter, women have a higher blood pressure ([@b6]). This sex-based difference appears to be particularly pronounced in the elderly. For instance, in the United States the prevalence of hypertension is approximately 34% for both men and women aged 45--64. However, in the 75%+ cohort women have an increased prevalence of high blood pressure than men (83 vs 69%, respectively) ([@b6]). Although men (under the age of 75) have greater prevalence of coronary heart disease, women have a greater prevalence of CVD events due to heart failure ([@b6]).

The death rates associated with a myocardial infarction appear to be higher in women than men ([@b51]; [@b48]). For instance, in the United States, 25% of men and 38% of women die within one year after have an initial myocardial infarction ([@b6]). This may be in part due to the fact that women are often older when they have a myocardial infarction. More American women (64%) than men (50%) who die suddenly due to CVD had no previous symptoms ([@b6]).

There is an increased incidence of osteoporosis in women (approximately 80%) ([@b105]). The incidence of osteoporosis increases markedly after the age of menopause with approximately 1 in 4 women over the age of 50 exhibiting osteoporosis ([@b106]). This has led to a primary focus on elderly women in research within the field; however, approximately 30% of hip fractures occur in men. Men also have a higher risk of dying after a fracture ([@b33]). It has been estimated that the mortality rate in the first year after a fracture in men is twice that of women ([@b167]).

Risk management of cardiovascular disease and osteoporosis
==========================================================

With the projected progressive increase in life expectancy it is clear that the incidence of both CVD and osteoporosis will increase for both males and females. Therefore, effective preventive interventions are required to offset the inevitable burden these chronic conditions will place upon society. It is also important to note, that with the global increase in life expectancy a major challenge for public health care systems will be the enhancement of overall quality of life, and not solely the prevention of chronic disease. Life expectancy does not take into account the years a person may live in a dependent or diseased state. Since overall quality of life is of utmost importance (especially as one ages) recent health agencies (such as the World Health Organization) have adopted new criteria to determine the number of years a person might live in a healthy state. For instance, the World Health Organization has recently introduced the Health-Adjusted Life Expectancy (HALE) scale that takes into account the anticipated years of ill-health to provide an estimate of years of healthy living ([Figure 2](#fig2){ref-type="fig"}).
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Health-related quality of life includes physiological, functional, emotional and spiritual well-being. We have discussed previously the physiological determinants of chronic disease. However, a holistic approach to health care should also include the evaluation of the other determinants of health-related quality of life. For instance, emotional and spiritual well-being are key factors in maintaining a high quality of life across the lifespan ([@b151], [@b152]). Moreover, the maintenance of functional capacity is fundamental to healthy aging ([@b151], [@b152]). Functional independence, especially as one ages, is related largely to one's ability to perform activities of daily living. In fact, the capacity to carry out activities of daily living is thought to be of greater concern to the elderly than chronic disease ([@b41]; [@b151], [@b152], [@b154]). Therefore, preventative strategies should be developed that not only specifically target individual risk factors for chronic disease, but also address the emotional, physical and social well-being of the individual ([@b151], [@b152]; [@b107]).

It is essential to stress that preventative strategies for both CVD and osteoporosis should not focus solely on the elderly at the expense of younger generations ([@b33]). It is clear that CVD starts in childhood and progresses with advancing age. It has been estimated that approximately one half of North American children exhibit one or more risk factor for CVD, with up to a third exhibiting at least one risk factor by the time they enter elementary school ([@b44]). In fact, many children and adolescents exhibit multiple risk factors for CVD ([@b143]; [@b17]; [@b98]). As discussed previously, we have recently shown that 8% of elementary children had four or more CVD risk factors ([@b99]). This is of concern owing to the fact that the severity of underlying cardiovascular disease is greater with increasing numbers of CVD risk factors ([@b17]) and these children may be more likely to develop CVD in adulthood ([@b116]). Moreover, childhood and adolescence are important periods for the development of bone health. In fact, approximately 90% of adult bone mass is accrued by the end of adolescence ([@b100]). Effective interventions (in particular interventions involving mechanical loading) can have marked effects upon bone metabolism and health during the growing years ([@b100]). For instance, exercise interventions have been shown to have a greater effect when started in premenarche compared to postmenarche ([@b75]). It appears that benefits derived from interventions that optimize peak bone mass (such as weight-bearing exercise) may extend into adulthood ([@b79]). Therefore, preventative interventions must be devised that meet the needs of individuals from across the lifespan.

We feel that a preventative model across the lifespan is required to effectively address the high prevalence of CVD and osteoporosis, and to improve overall quality of life. Given the interrelationships between multiple chronic disease states a holistic approach to medicine should be advocated. In short, rather than focusing on the prevention and treatment of single disease states we should consider the treatment of the whole patient. Physical activity interventions have shown this strategy will hold great potential for addressing concurrently multiple chronic diseases, while improving overall quality of life.

Does minimizing the risk in one disease predispose an individual to risk in the other?
======================================================================================

As discussed above, effective interventions can concurrently target multiple modifiable risk factors for both CVD and osteoporosis. For instance, the cessation of smoking and an increase in weight-bearing physical activity would each have a beneficial effect on both chronic conditions. However, clinicians must be aware that there is the potential for the reduction of risk in one disease to predispose the individual to an increased risk for the other condition. Perhaps the best example of this is weight reduction for the treatment of CVD. This is owing to the fact that a low BMI is an independent predictor of the risk for osteoporosis ([@b36]). For instance, [@b36] revealed that a BMI of 20 kg/m^2^ was associated with a 2-fold increase in the risk for hip fracture in comparison to a BMI of 25 kg/m^2^. The risk for hip fracture however does not appear to be linear across BMI levels, as a BMI of 30 kg/m^2^ only conferred a 17% reduction in hip fracture risk in comparison to a BMI of 25 kg/m^2^. It appears that weight loss is also associated with an increased risk for osteoporosis ([@b40]; [@b93]). [@b93] recommended that postmenopausal women (who are not taking hormone-replacement therapy) should be informed that low body weight or losing weight may worsen the degree of bone loss. Therefore, although losing weight confers health benefits for CVD, it may be counterproductive for osteoporosis. However, the level of weight loss often achieved in patients with CVD after lifestyle and/or pharmacological interventions is often not excessive and as such may confer limited additional risk for the development of osteoporosis. In fact, given the apparent relationship between CVD and osteoporosis it is likely that the changes in vascular health would be of great health benefit to the individual patient. It is important to note, that there are interventions (such as physical activity) that can meet the needs of both chronic conditions without markedly compromising the cardiovascular or skeletal health. This is particularly salient given the beneficial exercise-associated changes in bone and vascular health.

Hormone replacement therapy
---------------------------

Postmenopausal hormone therapy has been widely advocated for the prevention of osteoporosis and the treatment of postmenopausal symptoms ([@b24]). It was also anticipated that estrogen replacement therapy or combined estrogen-progestin therapy (hormone replacement therapy) would lower CVD risk ([@b4]). In fact, during the early 1990s hormone therapy was widely promoted as an effective primary and secondary preventive strategy against CVD ([@b118]). This was based largely on epidemiological (observational) studies that demonstrated a beneficial effect of hormone replacement therapy on risk factors and outcomes for CVD ([@b131]; [@b54]). However, the results of hormone replacement therapy clinical trials have had conflicting effects with respect to the risk for CVD. For instance, the Heart and Estrogen/Progestin Replacement Studies (HERS I and II) ([@b69]; [@b49]) and the Women's Estrogen for Stroke Trial (WEST) ([@b146]) did not show a reduction in the incidence of CVD. Moreover, the Women's Health Initiative (WHI) terminated early the trial of estrogen plus progestin owing to increased risks of breast cancer and cardiovascular events ([@b119]). Recently, [@b4] revealed that 2--3 years of hormone replacement therapy does not increase all-cause mortality and may lead to cardiovascular health benefits (including decreased severity of aortic calcification). Owing to the discrepancies in the field, it is apparent that hormone replacement therapy should be used cautiously considering the risk benefit ratio for each individual patient.

Priority: Cardiovascular disease versus osteoporosis
====================================================

Physicians and health care professionals are often met with the challenge of assessing and managing the risk of individuals with varied medical conditions (such as multiple chronic diseases). In terms of screening and risk management osteoporosis is often considered to be of lower priority than cardiovascular disease.

While the incidence of CVD-related mortality and morbidity is shown to be greater than that for osteoporosis, the importance of preventing and treating osteoporosis cannot be discounted. As discussed previously, osteoporosis affects a significant proportion of society (in particular elderly women). Further, as the population ages, these numbers are expected to increase substantially ([@b144]). The economic and societal implications of osteoporosis are considerable owing to the significant morbidity, mortality, and health care costs associated with osteoporotic fractures ([@b122]; [@b96]). According to [@b122], in the United States alone, the average annual direct costs of osteoporosis per patient is \$6,259 while the indirect cost associated with the disease is \$4,039 demonstrating a significant financial burden. Therefore, overcoming the challenge of providing optimal health care while managing the costs associated with treatment is of great concern (especially as the population ages) ([@b96]; [@b144]). [@b144] suggests that in order to control costs, post-fracture care and identification of individuals with an increased risk of fracture may enable cost-effective management and treatment of osteoporosis. It is therefore necessary to ensure effective preventative measures and treatment protocols in order to reduce the number of individuals at risk of developing osteoporosis and experiencing an osteoporosis-related fracture ([@b144]).

Fortunately, exercise interventions can help address both CVD and osteoporosis concurrently, thereby limiting the need for clinicians to prioritize between conditions. In fact, it is likely that primary and secondary prevention through healthy lifestyle interventions may serve to decrease the physical, social, emotional and spiritual impairments to the individual as well as decrease the direct and indirect medical costs associated with the treatment of both conditions.

Physical activity and its role in the prevention of CVD and osteoporosis
========================================================================

Physical inactivity is a major risk factor for both osteoporosis and CVD ([@b154], [@b155]). There is also extensive literature indicating that physical activity is an effective primary and secondary preventive strategy against CVD, osteoporosis, and multiple other chronic diseases (including obesity, stroke, hypertension, type 2 diabetes, colon cancer, breast cancer, and several psychological disorders) ([@b154]).

Being fit or physically active has been shown to lead to a 30%--50% reduction in the risk of death from any cause and from CVD ([@b154]). Low maximal aerobic fitness is as important a risk factor for premature mortality as is overweight and obesity ([@b19]). Several mechanisms may explain the reduced premature mortality rates and incidence of CVD in individuals who are habitually active ([@b154], [@b155]). For instance, regular aerobic exercise has been shown to improve body composition (via reduced abdominal adiposity and/or improved weight control) ([@b142]; [@b125]; [@b128]; [@b95]), enhance lipid lipoprotein profiles (including increased HDL-cholesterol, reduced triglycerides, and decreased LDL-cholesterol) ([@b137]; [@b56]; [@b18]), improve glucose homeostasis ([@b150]; [@b77]), decrease blood pressure ([@b5]; [@b155]), reduce systemic inflammation ([@b2]), enhance cardiac function [@b157], [@b153], [@b156]), and improve endothelial function ([@b47]; [@b57]; [@b83]).

Particularly relevant to this discussion is the exercise-mediated changes in vascular health and endothelial function. Several studies have evaluated the effects of habitual exercise on endothelial function in elderly and patient populations. Cross-sectional investigations have revealed that active older adults have improved vascular health in comparison to sedentary individuals ([@b136]; [@b101]; [@b45]). Moreover, habitual physical activity appears to attenuate the age-associated decline in endothelial function ([@b136]; [@b45], [@b46]). Research trials have also revealed the ability of exercise interventions to improve vascular health and endothelial function in asymptomatic and symptomatic populations ([@b58], [@b59], [@b57]; [@b47]; [@b83]) (with the beneficial adaptations being particularly apparent in clinical populations ([@b50])).

A direct relationship exists between lifetime physical activity and bone health. In particular, weight-bearing exercise appears to have a great effect on bone mineral density ([@b151], [@b152], [@b154]). For instance, adults performing repetitive, high-intensity, weight-bearing exercise consistently have greater BMD than sedentary individuals ([@b16]; [@b66]; [@b92]; [@b151], [@b152]). Prospective studies in post-menopausal women using weight bearing activity have often reported an increase or maintenance of total body, hip, and lumbar spine bone mineral density ([@b62]; [@b158]; [@b84]). In fact, resistance training often results in site-specific and load-dependent improvements in BMD ([@b129]; [@b78]; [@b84]; [@b151], [@b152]). A meta-analysis of randomized controlled trials reported that exercise training interventions result in the prevention or reversal of approximately 1% of bone loss per year in the lumbar spine and femoral neck in both pre- and post-menopausal women ([@b163]). Moreover, exercise training has been shown to reduce the risk and number of falls ([@b140]; [@b162]; [@b126]; [@b29], [@b30]; [@b90]) and fractures ([@b134]; [@b71]; [@b52]; [@b85]). Preliminary evidence also indicates that routine physical activity is effective in improving bone density in older women with low bone mineral density ([@b91]).

It is clear that regular physical activity prolongs one's lifespan ([@b88]), but it also delays greatly the onset of chronic disease and/or disability. Therefore, physical activity is an effective means to increase the number of years that a person lives in a healthy state, thereby minimizing the years spent in a dependent state. If disability does occur it is generally for a short period of time at the end of life ([@b113]). This is particularly important with the ever-increasing aging population.

Summary
=======

It is clear that both CVD and osteoporosis are major health burdens affecting millions of people globally. A growing body of research supports a direct association between CVD and osteoporosis providing an explanation for why (in part) individuals often exhibit both chronic conditions. There are numerous factors that may account for this relationship including risk factors that are common to both debilitating chronic conditions, and varied pathophysiological mechanisms. Both chronic conditions share similar modifiable risk factors (including physical inactivity) and such effective treatment strategies can be developed to address both diseases.

There appear to be distinct differences between (and within) sexes across the lifespan with respect to each chronic condition that need to be considered when treating the individual patient. It is important to have an understanding of the effects of varied primary and secondary preventative strategies on multiple chronic conditions. Preventative strategies should not only target individual risk factors for chronic disease, but also address the overall health-related quality of life of the individual. We advocate a holistic approach to the prevention and treatment of these chronic debilitating diseases; an approach that considers the social, emotional, spiritual and physical well-being of the individual.

When designing an intervention (such as a physical activity intervention) to address both chronic conditions, clinicians must be able to balance the risk of each condition. Clinicians must be aware that there is a potential for the risk reduction in one disease to predispose the individual to an increased risk for the other condition. With this knowledge, clinicians will be able to develop effective interventions that attenuate the risk while addressing the specific limitations of each chronic condition.

Although CVD takes a higher toll on society in terms of premature mortality, morbidity rates, and health care costs, the importance of the prevention/treatment of osteoporosis (particularly in elderly women) can not be overlooked. Habitual physical activity is an effective primary and secondary preventative strategy for both chronic conditions across the lifespan. Training-induced adaptations in endothelial function appear to be particularly important for the concurrent reductions in the risk of CVD and osteoporosis.
